INM InMed Pharmaceuticals Inc.

Nasdaq inmedpharma.com


$ 1.80 $ 0.08 (4.62 %)    

Thursday, 13-Nov-2025 15:59:13 EST
QQQ $ 608.59 $ -9.26 (-1.5 %)
DIA $ 475.50 $ -6.59 (-1.37 %)
SPY $ 672.57 $ -8.41 (-1.24 %)
TLT $ 89.38 $ -0.42 (-0.46 %)
GLD $ 384.40 $ -4.31 (-1.11 %)
$ 1.81
$ 1.89
$ 1.78 x 500
$ 1.85 x 50
-- - --
$ 1.56 - $ 8.27
223,046
na
nm
$ 2.21
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 09-22-2025 06-30-2025 10-K
3 05-12-2025 03-31-2025 10-Q
4 02-12-2025 12-31-2024 10-Q
5 11-14-2024 09-30-2024 10-Q
6 09-27-2024 06-30-2024 10-K
7 05-13-2024 03-31-2024 10-Q
8 02-13-2024 12-31-2023 10-Q
9 11-13-2023 09-30-2023 10-Q
10 09-29-2023 06-30-2023 10-K
11 05-15-2023 03-31-2023 10-Q
12 02-17-2023 12-31-2022 10-Q
13 11-14-2022 09-30-2022 10-Q
14 09-23-2022 06-30-2022 10-K
15 05-13-2022 03-31-2022 10-Q
16 02-14-2022 12-31-2021 10-Q
17 11-10-2021 09-30-2021 10-Q
18 09-24-2021 06-30-2021 10-K
19 05-13-2021 03-31-2021 10-Q
20 02-11-2021 12-31-2020 10-Q
21 12-17-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 inmed-pharmaceuticals-will-be-issued-us-patent-number-12357604-tomorrow-titled-topical-formulations-of-cannabinoids-and-use-thereof-in-the-treatment-of-pain

https://x.com/PatentGrants/status/1944848362106462423

 on-june-24-2025-inmed-pharmaceuticals-entered-agreement-to-sell-19m-shares-at-2561-each

-SEC Filing

 why-inmeds-alzheimers-drug-candidate-is-fueling-sudden-stock-surge

InMed stock jumped after preclinical data showed INM-901 lowered brain inflammation tied to Alzheimer's and improved cognit...

Core News & Articles
Market-Moving News for June 24th
06/24/2025 11:16:06

INM: 102% | InMed shares are trading higher after the company announced preclinical data showing INM-901 reduced neuroinflammat...

 inmed-pharmaceuticals-amends-standby-equity-purchase-agreement-with-yorkville-may-from-time-to-time-suspend-use-of-registration-statement-of-shares-under-sepa-with-yorkville

-SEC Filing

 why-inmed-pharmaceuticals-inm-stock-is-skyrocketing

InMed Pharmaceuticals shares are trading higher by 45% during Tuesday's session. The company announced that INM-901 reduced...

 inmed-pharmaceuticals-announces-inm-901-reduced-alzheimers-related-inflammation-achieved-statistically-significant-reduction-in-neurodegeneration-marker-neurofilament-light-chain-and-neuroinflammatory-genes-in-preclinical-study

INM-901 significantly reduced pro-inflammatory cytokines associated with Alzheimer'sStatistically significant reduction in ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION